Pharmacologic treatment approaches for children and adolescents with posttraumatic stress disorder

Child and Adolescent Psychiatric Clinics of North America

Volumn 12, Issue 2, 2003, Pages 251-269

  Donnelly, Craig L ^a  

^a DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENERGIC RECEPTOR STIMULATING AGENT; ALPRAZOLAM; AMFEBUTAMONE; AMITRIPTYLINE; ATOMOXETINE; ATYPICAL ANTIPSYCHOTIC AGENT; BUSPIRONE; CITALOPRAM; CLOMIPRAMINE; CLONAZEPAM; CLONIDINE; CYPROHEPTADINE; ESCITALOPRAM; FLUOXETINE; FLUVOXAMINE; GUANFACINE; IMIPRAMINE; MIRTAZAPINE; NEFAZODONE; OLANZAPINE; PAROXETINE; PHENELZINE; PROPRANOLOL; PSYCHOSTIMULANT AGENT; QUETIAPINE; RISPERIDONE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRAZODONE; UNCLASSIFIED DRUG; VENLAFAXINE;

AGGRESSION; ANXIETY DISORDER; ATTENTION DEFICIT DISORDER; AUTOMUTILATION; BEHAVIOR THERAPY; CHILD PARENT RELATION; CHILD PSYCHIATRY; COGNITIVE THERAPY; COMORBIDITY; DAILY LIFE ACTIVITY; DEPRESSION; DISEASE ASSOCIATION; DISEASE SEVERITY; DISSOCIATION; DOSE RESPONSE; DRUG EFFICACY; FUNCTIONAL ASSESSMENT; HEALTH EDUCATION; HUMAN; IMPULSIVENESS; INSOMNIA; JOB PERFORMANCE; LIFE EVENT; MENTAL DISEASE; MOOD DISORDER; MORBIDITY; POSTTRAUMATIC STRESS DISORDER; PRIORITY JOURNAL; PSYCHODYNAMICS; PSYCHOPHARMACOTHERAPY; PSYCHOSIS; REVIEW; SOCIAL ASPECT; SYMPTOMATOLOGY; TREATMENT OUTCOME; TREATMENT PLANNING;

EID: 0037387382     PISSN: 10564993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1056-4993(02)00102-5     Document Type: Review

References (82)

1. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th edition. Washington, DC: American Psychiatric Association; 1994.
2. Famularo R, Kinscherff R, Fenton T. Psychiatric diagnoses of maltreated children: preliminary findings. J Am Acad Child Adolesc Psychiatry 1992;31:863-7.
3. Ford JD, Racusin R, Ellis CG, Daviss WB, Reiser J, Fleischer A, et al. Child maltreatment, other trauma exposure, and posttraumatic symptomatology among children with oppositional defiant and attention deficit hyperactivity disorders. Child Maltreatment 2000;5:205-17.
4. Goldman SJ, D'Angelo EJ, DeMaso DR, et al. Physical and sexual abuse histories among children with borderline personality disorder. Am J Psychiatry 1992;149:1723-6.
5. Pynoos RS, Frederick CJ, Nader K, et al. Life threat and posttraumatic stress in school-age children. Arch Gen Psychiatry 1987;44:1057-63.
6. Seedat S, Kaminer D, Lockhat R, Stein DJ. An overview of post-traumatic stress disorder in children and adolescents. Primary Care Psychiatry 2000;6:43-8.
7. Wozniak J, Crawford MH, Biederman J, Faraone SV, Spencer TJ, Taylor A, et al. Antecedents and complications of trauma in boys with ADHD: findings from a longitudinal study. J Am Acad Child Adolesc Psychiatry 1999;38:48-56.
8. Breslau N. Epidemiology of trauma and posttraumatic stress disorder in psychological trauma. In: Yehuda R, editor. Risk factors for posttraumatic stress disorder. Washington, DC: American Psychiatric Press; 1998. p. 1-29.
9. Kessler RC, Sonnega A, Bromet E, Hughes M, Nelson CB. Posttraumatic stress disorder in the National Comorbidity Survey. Arch Gen Psychiatry 1995;52:1048-60.
10. Muller RT, Sicoli LA, Lemieux KE. Relationshp between attachment style and posttraumatic stress symptomatology among adults who report the experience of childhood abuse. J Trauma Stress 2000;13:321-32.
11. Cohen JA, Mannarino AP, Rogal S. Treatment practices for childhood posttraumatic stress disorder. Child Abuse Negl 2001;25:123-35.
12. De Bellis MD, Chrousos GP, Dom LD, et al. Hypothalamic-pituitary-adrenal axis dysregulation in sexually abused girls (see comments). J Clin Endocrinol Metab 1994;78:249-55.
13. De Bellis MD, Lefter L, Trickett PK, et al. Urinary catecholamine excretion in sexually abused girls. J Am Acad Child Adolesc Psychiatry 1994;33:320-7.
14. Perry BD. Neurobiological sequelae of childhood trauma: PTSD in children. Washington, DC: American Psychiatric Press; 1994. p. 233-55.
15. Perry BD, Pate JE. Neurodevelopment and the psychobiological roots of post-traumatic stress disorder. Springfield (IL): Charles C. Thomas; 1994.
16. De Bellis MD, Baum AS, Birmaher B, Keshavan MS, et al. Developmental traumatology. Part I & II. Biological stress systems. Biol Psychiatry 1999;45:1259-84.
17. Bremner JD, Davis M, Southwick SM, et al. Neurobiology of posttraumatic stress disorder. In: Oldham JM, Riba MB, Tasman A, editors. Review of psychiatry. Washington, DC: American Psychiatric Press; 1993. p. 183-205.
18. Charney DS, Deutch AY, Krystal JH, Southwick SM, Davis M. Psychobiological mechanisms of posttraumatic stress disorder. Arch Gen Psychiatry 1993;50:294-305.
19. Donnelly CL, Amaya-Jackson L. Post-traumatic stress disorder in children and adolescents: epidemiology, diagnosis and treatment options. Ped Drugs 2002;4:159-70.
20. Foa EB, Davidson JRT, Frances A. The expert consensus guideline series: treatment of post-traumatic stress disorder. J Clin Psychiatry 1999;60(Suppl 16):6-76.
21. Friedman M, Davidson JR, Mellman TA, Southwick SM. Guidelines for pharmacotherapy and position paper on practice guidelines. In: Foa EB, Keane TM, Friedman MJ, editors. Effective treatments for post-traumatic stress disorder: practice guidelines from the International Society for Traumatic Stress Studies. New York: Guilford Press; 2000. p. 84-105.
22. Yehuda R. Recent developments in the neuroendocrinology of posttraumatic stress disorder. CNS Spectrums. International Journal of Neuropsychiatric Medicine 1998;3(Suppl 2):22-9.
23. Yehuda R. Post-traumatic stress disorder. N Engl J Med 2002;346:108-14.
24. Heim C, Newport DJ, Bonsall R, Miller AH, Nemeroff CB. Altered pituitary-adrenal axis responses to provocative challenge tests in adult survivors of childhood abuse. Am J Psychiatry 2001;158:575-81.
25. Heit S, Graham Y, Nemeroff CB. Neurobiological effects of early trauma. Harvard Mental Health Letter 1999;16:4-6.
26. Wilson SN, van der Kolk B, Burbridge J, Fisler R, Kradin R. Phenotype of blood lymphocytes in PTSD suggest chronic immune activation. Psychosomatics 1999;40:222-5.
27. Ornitz E, Pynoos R. Startle modulation in children with post-traumatic stress disorder. Am J Psychiatry 1989;146:866-70.
28. Putnam FW, Trickett PK. Child sexual abuse: a model of chronic trauma. Psychiatry 1993;56:82-95.
29. De Bellis MD. A pilot study of hippocampal volumes in pediatric maltreatment-related post-traumatic stress disorder. Biol Psychol 2001;50:305-9.
30. Cicchetti D, Rogosch FA. Diverse patterns of neuroendocrine activity in maltreated children. Dev Psychopathol 2001;13:677-93.
31. King JA, Mandansky D, King S, Fletcher KE, Brewer J. Early sexual abuse and low cortisol. Psychiatr Clin Neurosci 2001;55:71-4.
32. Pitman RK. Biological findings in posttraumatic stress disorder: implications for DSM-IV classification. In: Davidson JRT, Foa EB, editors. Posttraumatic stress disorder: DSM-IV and beyond. Washington, DC: American Psychiatric Press; 1993. p. 173-89.
33. Yule W, Canterbury R. The treatment of post traumatic stress disorder in children and adolescents. International Review of Psychiatry 1994;6(2-3):141-51.
34. Donnelly CL, Amaya-Jackson L, March JS. Psychopharmacology of pediatric posttraumatic stress disorder. J Child Adolesc Psychopharmacol 1999;9:203-20.
35. Cohen JA. Practice parameters for the assessment and treatment of children and adolescents with posttraumatic stress disorder. J Am Acad Child Adolesc Psychiatry 1998;37(Suppl): 4s-26s.
36. Kutcher SP. Practical child and adolescent psychopharmacology. Cambridge: Cambridge University Press; 2002.
37. Pfefferbaum B. Posttraumatic stress disorder in children: a review of the past 10 years. J Am Acad Child Adolesc Psychiatry 1997;36:1503-11.
38. Riddle MA, Kastelic EA, Frosch E. Pediatric psychopharmacology. J Child Psychol Psychiatry 2001;42:73-90.
39. March JS, Amaya-Jackson L. Post-traumatic stress disorder in children and adolescents. PTSD Research Quarterly 1994;4:1-7.
40. March JS, Amaya-Jackson L, Costanzo P, et al. Post-traumatic stress in children and adolescents after an industrial fire. Presented at the annual meeting of the Anxiety Disorders Association of America. Pittsburgh, April 1995.
41. Davidson JRT, Pearlstein T, Londborg P, et al. Efficacy of sertraline in preventing relapse of posttraumatic stress disorder: results of a 28-week double-blind, placebo-controlled study. Am J Psychiatry 2002;158:1974-81.
42. Friedman MJ. Current and future drug treatment for post-traumatic stress disorder patients. Psych Annals 1998;28:461-8.
43. Friedman MJ. A guide to the literature on pharmacotherapy for PTSD. PTSD Research Quarterly 2000;11:1-3.
44. Hidalgo RB, Davidson JR. Selective serotonin reuptake inhibitors in post-traumatic stress disorder. J Psychopharmacol 2000;14:70-6.
45. Brady K, Pearlstein T, Asnis GM, Baker D, Rothbaum B, Sikes CR, et al. Efficacy and safety of sertraline treatment of posttraumatic stress disorder: a randomized controlled trial. JAMA 2000;283:1837-44.
46. Marshall RD, Beebe KL, Oldham M, Zaninelli R. Efficacy and safety of paroxetine treatment for chronic PTSD: a fixed-dose, placebo-controlled study. Am J Psychiatry 2001;158:1982-8.
47. Horrigan JP. Guanfacine for posttraumatic stress disorder nightmares [letter]. J Am Acad Child Adolesc Psychiatry 1996;35:975-6.
48. Marmar CR, Foy D, Kagan B, Pynoos RS. An integrated approach for treating post-traumatic stress. In: Pynoos RS, editor. Post-traumatic stress disorder: a clinical review. Lutherville (MD): Sidran Press; 1993. p. 65-98.
49. Harmon RJ, Riggs PD. Clinical perspectives: clonidine for posttraumatic stress disorder in preschool children. J Am Acad Child Adolesc Psychiatry 1996;35:1247-9.
50. Horrigan JP, Bamhill LJ. The suppression of nightmares with guanfacine [letter]. J Clin Psychiatry 1996;57:371.
51. Famularo R, Kinscherff R, Fenton T. Propranolol treatment for childhood posttraumatic stress disorder, acute type. Am J Dis Child 1988;142:1244-7.
52. Horrigan JP, Bamhill LJ. Risperidone and PTSD in boys. J Neuropsychiatry Clin Neurosci 1999;11:126-7.
53. Benkelfat C. Serotonergic mechanisms in psychiatric disorders: new research tools, new ideas. Int Clin Psychopharmacol 1993;8(Suppl 2):53-6.
54. Van der Kolk BA, Perry JC, Herman JL. Childhood origins of self-destructive behavior. Am J Psychiatry 1991;148:1655-71.
55. Southwick SM, Yehuda R, Giller EL, Chamey DS. Use of tricyclics and monoamine oxidase inhibitors in the treatment of PTSD: a quantitative review. In: Marburg MM, editor. CatechoIamine function in post-traumatic stress disorder: emerging concepts. Washington, DC: American Psychiatric Press; 1994. p. 293-305.
56. Seedat S, Lockhat R, Kaminer D, Zungu-Dirwayi N, Stein DJ. An open trial of citalopram in adolescents with post-traumatic stress disorder. Int Clin Psychopharmacol 2001;16: 21-5.
57. Brent DA, Perper JA, Moritz G, et al. Posttraumatic stress disorder in peers of adolescent suicide victims. J Am Acad Child Adolesc Psychiatry 1995;34:209-15.
58. Domon SE, Anderson MS. Nefazadone for PTSD. J Am Acad Child Adolesc Psychiatry 2000; 39:942-3.
59. Conner KM, Davidson JR, Weisler RH, Ahearn E. A pilot study of mirtazapine in post-traumatic stress disorder. Int Clin Psychopharmacol 1999;14:29-31.
60. Good C, Peterson C. SSRI and mirtazapine in PTSD. J Am Acad Child Adolesc Psychiatry 2001;40:263-4.
61. Wells GB, Chu C, Johnson R. Buspirone in the treatment of post-traumatic stress disorder. J Clin Psychiatry 1991;55:517-22.
62. Brophy MH. Cyproheptadine for combat nightmares in posttraumatic stress disorder and dream anxiety disorder. Mil Med 1991;156:100-1.
63. Robert R, Blakeney PE, Villarreal C, Rosenberg L, Meyer WJ. Imipramine treatment in pediatric burn patients with symptoms of acute stress disorder: a pilot study. J Am Acad Child Adolesc Psychiatry 1999;38:873-82.
64. Lipper S, Davidson JR, Grady TA, Edinger JD, Hammett EB, Mahomey SL, et al. Preliminary study of carbemazepine in post-traumatic stress disorder. Psychosomatics 1986;27:849-54.
65. Loof D, Grimley P, Kuller F, Martin A, Shonfield L. Carbemazepine for PTSD. J Am Acad Child Adolesc Psychiatry 1995;34:703-4.
66. Fessler FA. Valproate in combat-related post-traumatic stress disorder. J Clin Psychiatry 1991; 52:361-4.
67. Daviss WB. Efficacy and tolerability of buproprion in boys with ADHD and major depression or dysthymic disorder. Child Adolesc Psychopharmacol Update 1999;1:6.
68. Nader KO. Assessing traumatic experiences in children. In: Wilson JP, Keane TM, editors. Assessing psychological trauma and PTSD. London: Guilford Press; 1997. p. 291-348.
69. Nader K, Stuber M, Pynoos RS. Posttraumatic stress reactions in preschool children with catastrophic illness: assessment needs. Comprehensive Mental Health Care 1991;1:223-39.
70. March JS, Albano AM. Assessment of anxiety in children and adolescents. In: Dickstein LJ, Riba MB, Oldham JM, editors. American psychiatric press annual review of psychiatry. Washington, DC: American Psychiatric Press; 1996. p. 405-27.
71. Blake DD, Weathers FW, Nagy LM, et al. The development of clinician-administered PTSD scale. J Trauma Stress 1995;8:75-89.
72. Nader K, Blake D, Kriegler J, et al. Clinician administered PTSD scale for children (CAPS-C): current and lifetime diagnosis version, and instruction manual. Los Angeles: UCLA Neuropsychiatric Institute and National Center for PTSD; 1994.
73. Keane TM, Weathers FW, Foa EB. Diagnosis and assessment. In: Foa EB, Keane TM, Friedman MJ, editors. Effective treatments for post-traumatic stress disorder: practice guidelines from the International Society for Traumatic Stress Studies. New York: Guilford Press; 2000. p. 18-36.
74. Lonigan CJ, Shannon MP, Finch AJ, et al. Children's reactions to a natural disaster: symptom severity and degree of exposure. Advances in Behavior Research and Therapy 1991;13: 135-54.
75. Costello E. Developments in child psychiatric epidemiology. J Am Acad Child Adolesc Psychiatry 1989;28:836-41.
76. Amaya-Jackson L, March J. Post-traumatic stress disorder in children and adolescents. Child Adolesc Psychiatr Clin N Am 1993;2:639-54.
77. Scheeringa MS. Treatment for posttraumatic stress disorder in infants and toddlers. Journal Syst Ther 1995;18:21-31.
78. Conners C, March J, Erhardt D, et al. Assessment of attention-deficit disorders. Journal of Psychoeducational Assessment 1995;28:186-205.
79. Swanson JM. School-based assessments and interventions for ADD students. Irvine (CA): KC Publications; 1992.
80. Kovacs M. The Children's Depression Inventory (CDI). Psychopharmacol Bull 1985;21:995-8.
81. March JS, Parker J, Sullivan K, et al. The multidimensional anxiety scale for children (MASC) factor structure, reliability, and validity. J Am Acad Child Adolesc Psychiatry 1995; 36(4):554-65.
82. Ohan J, Myers K, Corlett B. Ten-year review of rating scales. IV: scales assessing trauma and its effects. J Amer Acad Child Adolesc Psychiatry 2002;41:1401-22.